Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Characterization of the Earliest Adopters of Subcutaneous FcRn Blockers for gMG

Author:Kuhlmann, Georgiana   Cloud, Blaine   

Session Name:P4: Autoimmune Neurology: Peripheral Autoimmunity  

Topic:Autoimmune Neurology  

Program Number:P4.013  

Author Institution:Spherix, Exton, PA  Spherix, Rydal, PA  

Modern Approaches to the Diagnosis of Patients with Parkinson’s Disease

Author:Mansurova, Nargiza   Madjidova, Yakuthon   Boymurodov, Ramazon   

Session Name:P4: Movement Disorders: Parkinson's Disease Clinical Aspects 1  

Topic:Movement Disorders  

Program Number:P4.014  

Author Institution:Tashkent pediatric medical institute, Tashkent, Uzbekistan  

Comorbid Pathology in Clinical Trial Participants: Autopsy Findings and Clinical Features

Author:Coskun, Pinar   Barber, Justin   Abner, Erin L.   Kryscio, Richard J.   Schmitt, Frederick A.   Goldstein, Larry   Van Eldik, Linda J.   Nelson, Peter T.   Jicha, Gregory A.   

Session Name:P4: Dementia and Behavioral Neurology: Non-AD Pathology 1  

Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

Program Number:P4.014  

Author Institution:University of Kentucky, Lexington, KY  

Clinical Characteristics and Outcomes of Neurofascin 186 IgG-associated Neuropathies

Author:Ibrahim, Ahmed   Dyck, P. James B.   Mills, John   Dubey, Divyanshu   

Session Name:P4: Autoimmune Neurology: Peripheral Autoimmunity  

Topic:Autoimmune Neurology  

Program Number:P4.015  

Author Institution:Mayo Clinic, Rochester, MN  

Patient Characteristics and Real-world Use of Botulinum Toxins for Treatment of Chronic Sialorrhea

Author:Hast, Michael   Kong, Amanda   Abdelhadi, Jenna   Szendrey, Andrew   Shah, Rohan   Holmes, Jordan   

Session Name:P4: Movement Disorders: Parkinson's Disease Clinical Aspects 1  

Topic:Movement Disorders  

Program Number:P4.017  

Author Institution:Merz Pharmaceuticals LLC, Raleigh, NC  Aetion, Inc, New York, NY